Works matching IS 00099104 AND DT 2022 AND VI 209 AND IP 3
Results: 10
Correction to: Metabolites: fuelling the immune response.
- Published in:
- 2022
- Publication type:
- Correction Notice
COVID-19 infection and vaccination in immunodeficiency.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 259, doi. 10.1093/cei/uxac080
- By:
- Publication type:
- Article
Immune mechanisms induced by sublingual immunotherapy in allergic respiratory diseases.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 262, doi. 10.1093/cei/uxac075
- By:
- Publication type:
- Article
E3 ubiquitin ligases STUB1/CHIP contributes to the Th17/Treg imbalance via the ubiquitination of aryl hydrocarbon receptor in rheumatoid arthritis.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 280, doi. 10.1093/cei/uxac072
- By:
- Publication type:
- Article
Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 270, doi. 10.1093/cei/uxac071
- By:
- Publication type:
- Article
AHNAK induces increased IL-6 production in CD4+ T cells and serves as a potential diagnostic biomarker for recurrent pregnancy loss.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 291, doi. 10.1093/cei/uxac067
- By:
- Publication type:
- Article
Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα pathway.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 316, doi. 10.1093/cei/uxac062
- By:
- Publication type:
- Article
Clinical value of the expression levels of protein tyrosine phosphatase non-receptor type 22.6 mRNA in peripheral blood mononuclear cells in Crohn's disease.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 311, doi. 10.1093/cei/uxac061
- By:
- Publication type:
- Article
Anti-glutathione S-transferase omega 1-1 (GSTO1-1) antibodies are increased during acute and chronic inflammation in humans.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 305, doi. 10.1093/cei/uxac060
- By:
- Publication type:
- Article
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 209, n. 3, p. 247, doi. 10.1093/cei/uxac008
- By:
- Publication type:
- Article